Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy.

[1]  Jian Sun,et al.  Elabela may regulate SIRT3‐mediated inhibition of oxidative stress through Foxo3a deacetylation preventing diabetic‐induced myocardial injury , 2020, Journal of cellular and molecular medicine.

[2]  L. Cai,et al.  Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy , 2020, Acta Pharmacologica Sinica.

[3]  T. Peng,et al.  Targeted inhibition of calpain in mitochondria alleviates oxidative stress-induced myocardial injury , 2020, Acta Pharmacologica Sinica.

[4]  M. Nagarkatti,et al.  Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice , 2020, Diabetes.

[5]  Jichun Liu,et al.  Curcumin protects cardiomyopathy damage through inhibiting the production of reactive oxygen species in type 2 diabetic mice. , 2020, Biochemical and biophysical research communications.

[6]  Mochao Xiao,et al.  GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunction. , 2020, Chemico-biological interactions.

[7]  P. Ponikowski,et al.  Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure , 2020, New England Journal of Medicine.

[8]  Xiangdong Gao,et al.  A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction. , 2020, Biochemical pharmacology.

[9]  Tong Liu,et al.  Xanthine oxidase inhibitor allopurinol improves atrial electrical remodeling in diabetic rats by inhibiting CaMKII/NCX signaling. , 2020, Life sciences.

[10]  Yue Zhang,et al.  Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation , 2020, Acta Pharmacologica Sinica.

[11]  Andrew P. Stubbs,et al.  Cellular, mitochondrial and molecular alterations associate with early left ventricular diastolic dysfunction in a porcine model of diabetic metabolic derangement , 2020, Scientific Reports.

[12]  Irshad Ahmad,et al.  Molecular mechanisms of action of resveratrol in modulation of diabetic and non-diabetic cardiomyopathy. , 2020, Pharmacological research.

[13]  Nicholas J. Carruthers,et al.  4‐Hydroxy‐2‐nonenal attenuates 8‐oxoguanine DNA glycosylase 1 activity , 2020, Journal of cellular biochemistry.

[14]  Lefeng Wang,et al.  Spiraeoside protects human cardiomyocytes against high glucose‐induced injury, oxidative stress, and apoptosis by activation of PI3K/Akt/Nrf2 pathway , 2020, Journal of biochemical and molecular toxicology.

[15]  A. Undas,et al.  Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes , 2020, Cardiovascular Diabetology.

[16]  Qian Su,et al.  SIRT3 is a downstream target of PPAR-α implicated in high glucose-induced cardiomyocyte injury in AC16 cells , 2020, Experimental and therapeutic medicine.

[17]  Yu-Han H. Hsu,et al.  Hepatic NADH reductive stress underlies common variation in metabolic traits , 2020, Nature.

[18]  R. Ritchie,et al.  Basic Mechanisms of Diabetic Heart Disease. , 2020, Circulation research.

[19]  F. Giorgino,et al.  The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor , 2020, Oxidative medicine and cellular longevity.

[20]  L. Maier,et al.  Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation. , 2020, Cardiovascular research.

[21]  F. Giallauria,et al.  Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement , 2020, Journal of clinical medicine.

[22]  P. Couvreur,et al.  Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents , 2020, Science Advances.

[23]  Qingguo Lu,et al.  Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet–Induced Obese Mice , 2020, Diabetes.

[24]  A. Banerjee,et al.  Altered composition of high-lipid diet may generate reactive oxygen species by disturbing the balance of antioxidant and free radicals , 2020, Journal of basic and clinical physiology and pharmacology.

[25]  C. Hoppel,et al.  Bioenergetic functions in subpopulations of heart mitochondria are preserved in a non-obese type 2 diabetes rat model (Goto-Kakizaki) , 2020, Scientific Reports.

[26]  H. Bugger,et al.  Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[27]  P. Moore,et al.  Induction of caveolin-3/eNOS complex by nitroxyl (HNO) ameliorates diabetic cardiomyopathy , 2020, Redox biology.

[28]  D. Prakoso,et al.  Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes , 2020, Frontiers in Physiology.

[29]  Jian-xing Ma,et al.  Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus , 2020, Theranostics.

[30]  C. Cheung,et al.  Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats , 2019, Journal of cellular and molecular medicine.

[31]  G. Balogh,et al.  Prediabetes Induced by Fructose-Enriched Diet Influences Cardiac Lipidome and Proteome and Leads to Deterioration of Cardiac Function prior to the Development of Excessive Oxidative Stress and Cell Damage , 2019, Oxidative medicine and cellular longevity.

[32]  Tong Liu,et al.  Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats , 2019, Cardiovascular Diabetology.

[33]  Ying Yu,et al.  ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation , 2019, Journal of diabetes research.

[34]  Fabio Marcheggiani,et al.  N-Acetyl cysteine ameliorates hyperglycemia-induced cardiomyocyte toxicity by improving mitochondrial energetics and enhancing endogenous Coenzyme Q9/10 levels , 2019, Toxicology reports.

[35]  Y. Liu,et al.  RNA‐Seq analysis and functional characterization revealed lncRNA NONRATT007560.2 regulated cardiomyocytes oxidative stress and apoptosis induced by high glucose , 2019, Journal of cellular biochemistry.

[36]  Jinying Zhang,et al.  Exogenous hydrogen sulfide protects against high glucose-induced apoptosis and oxidative stress by inhibiting the STAT3/HIF-1α pathway in H9c2 cardiomyocytes , 2019, Experimental and therapeutic medicine.

[37]  J. Shaw,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.

[38]  R. Yue,et al.  Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2/HO-1 and NF-κB pathways in diabetic cardiomyopathy. , 2019, Chemico-biological interactions.

[39]  T. Vilsbøll,et al.  Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. , 2019, The New England journal of medicine.

[40]  Liming Chen,et al.  Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice. , 2019, Clinical science.

[41]  H. Ren,et al.  Exogenous H2S reduces acetylation levels of mitochondrial respiratory enzymes via regulating NAD+-SIRT3 pathway in cardiac tissues of db/db mice. , 2019, American journal of physiology. Endocrinology and metabolism.

[42]  Lu Gao,et al.  Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects , 2019, Oxidative medicine and cellular longevity.

[43]  Zuo-ying Hu,et al.  Feature article: LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis , 2019, Experimental biology and medicine.

[44]  G. Liang,et al.  Blockage of ROS and MAPKs‐mediated inflammation via restoring SIRT1 by a new compound LF10 prevents type 1 diabetic cardiomyopathy , 2019, Toxicology and applied pharmacology.

[45]  Jian-xun Wang,et al.  Exenatide Protects Against Cardiac Dysfunction by Attenuating Oxidative Stress in the Diabetic Mouse Heart , 2019, Front. Endocrinol..

[46]  Yi‐Jen Chen,et al.  Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats , 2019, International journal of molecular sciences.

[47]  Liming Chen,et al.  SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart , 2019, Cardiovascular Diabetology.

[48]  Deepak L. Bhatt,et al.  Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes , 2019, The New England journal of medicine.

[49]  Marco Antonio Rodriguez,et al.  Nrf2‐related gene expression is impaired during a glucose challenge in type II diabetic rat hearts , 2019, Free radical biology & medicine.

[50]  L. Ye,et al.  Phloretin Prevents Diabetic Cardiomyopathy by Dissociating Keap1/Nrf2 Complex and Inhibiting Oxidative Stress , 2018, Front. Endocrinol..

[51]  Tong Liu,et al.  Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits , 2018, Cardiovascular Diabetology.

[52]  A. Voors,et al.  Treating oxidative stress in heart failure: past, present and future , 2018, European journal of heart failure.

[53]  Huanyuan Wang,et al.  Sitagliptin Protects Cardiac Function by Reducing Nitroxidative Stress and Promoting Autophagy in Zucker Diabetic Fatty (ZDF) Rats , 2018, Cardiovascular Drugs and Therapy.

[54]  G. Filippatos,et al.  Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology , 2018, European heart journal.

[55]  T. Lüscher,et al.  Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66Shc. , 2018, International journal of cardiology.

[56]  Shan Lu,et al.  HDAC11 deletion reduces fructose-induced cardiac dyslipidemia, apoptosis and inflammation by attenuating oxidative stress injury. , 2018, Biochemical and biophysical research communications.

[57]  Zhihong Yang,et al.  Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes , 2018, PloS one.

[58]  M. Sirdah,et al.  The effect of vitamin C and/or E supplementations on type 2 diabetic adult males under metformin treatment: A single-blinded randomized controlled clinical trial. , 2018, Diabetes & metabolic syndrome.

[59]  M. Nagarkatti,et al.  Nrf2 Exaggerates Cardiomyopathy Associated with Type 1 Diabetes in Mice , 2018, Diabetes.

[60]  M. Chonchol,et al.  Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults , 2018, Hypertension.

[61]  Cole M. Haynes,et al.  Activation of Nrf2 Is Required for Normal and ChREBPα-Augmented Glucose-Stimulated β-Cell Proliferation , 2018, Diabetes.

[62]  Zheng Wen,et al.  Glucagon‐like peptide‐1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway , 2018, Aging cell.

[63]  Qin M. Chen,et al.  Nrf2 at the heart of oxidative stress and cardiac protection. , 2018, Physiological genomics.

[64]  M. Giacca,et al.  An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology , 2018, European journal of heart failure.

[65]  D. Mochly‐Rosen,et al.  Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes , 2018, Cell Death & Differentiation.

[66]  H. Ren,et al.  Exogenous H2S switches cardiac energy substrate metabolism by regulating SIRT3 expression in db/db mice , 2018, Journal of Molecular Medicine.

[67]  Catalina Carrasco-Pozo,et al.  Quercetin Prevents Diastolic Dysfunction Induced by a High-Cholesterol Diet: Role of Oxidative Stress and Bioenergetics in Hyperglycemic Rats , 2018, Oxidative medicine and cellular longevity.

[68]  T. Sharp,et al.  Mitochondrial Reactive Oxygen Species in Lipotoxic Hearts Induce Post-Translational Modifications of AKAP121, DRP1, and OPA1 That Promote Mitochondrial Fission , 2018, Circulation research.

[69]  S. Zainalabidin,et al.  Cardioprotective Effects of Roselle (Hibiscus Sabdariffa Linn.) Polyphenol-Rich Extract in Streptozotocin-Induced Diabetic Rats , 2017 .

[70]  R. Curi,et al.  Comparison of Goto-Kakizaki rats and high fat diet-induced obese rats: Are they reliable models to study Type 2 Diabetes mellitus? , 2017, PloS one.

[71]  E. Tatsumi,et al.  Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE‐2/ANG 1–7/Mas receptor cascade , 2017, Biochemical pharmacology.

[72]  A. Natali,et al.  Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial , 2017, Cardiovascular Diabetology.

[73]  Neha J. Pagidipati,et al.  Effects of Once‐Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes , 2017, The New England journal of medicine.

[74]  H. Tomita,et al.  Thioredoxin 2 Offers Protection against Mitochondrial Oxidative Stress in H9c2 Cells and against Myocardial Hypertrophy Induced by Hyperglycemia , 2017, International journal of molecular sciences.

[75]  Yunfeng Zhu,et al.  The potential of chrysophanol in protecting against high fat-induced cardiac injury through Nrf2-regulated anti-inflammation, anti-oxidant and anti-fibrosis in Nrf2 knockout mice. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[76]  K. Mahaffey,et al.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes , 2017, The New England journal of medicine.

[77]  Jacob T Mey,et al.  Nox2 contributes to hyperinsulinemia-induced redox imbalance and impaired vascular function , 2017, Redox biology.

[78]  P. Couvreur,et al.  A Squalene-Based Nanomedicine for Oral Treatment of Colon Cancer. , 2017, Cancer research.

[79]  V. Demarco,et al.  Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice , 2017, Cardiovascular Diabetology.

[80]  N. Kaludercic,et al.  Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease , 2017, Current opinion in pharmacology.

[81]  Sa Shi,et al.  Sulfiredoxin involved in the protection of peroxiredoxins against hyperoxidation in the early hyperglycaemia , 2017, Experimental cell research.

[82]  S. Ghosh,et al.  A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans. , 2017, Journal of pharmacological and toxicological methods.

[83]  R. Ritchie,et al.  Insights into the role of maladaptive hexosamine biosynthesis and O‐GlcNAcylation in development of diabetic cardiac complications , 2017, Pharmacological research.

[84]  R. McKelvie,et al.  Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction) , 2017, Circulation.

[85]  D. Choi,et al.  Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression , 2017, Molecules.

[86]  H. Boeing,et al.  Dietary Supplements and Risk of Cause-Specific Death, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis of Primary Prevention Trials123 , 2017, Advances in nutrition.

[87]  C. Nediani,et al.  Monoamine Oxidase Is Overactivated in Left and Right Ventricles from Ischemic Hearts: An Intriguing Therapeutic Target , 2016, Oxidative medicine and cellular longevity.

[88]  Yi Tan,et al.  Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy , 2016, Diabetes.

[89]  S. Banerjee,et al.  Garlic activates SIRT-3 to prevent cardiac oxidative stress and mitochondrial dysfunction in diabetes. , 2016, Life sciences.

[90]  S. Xiong,et al.  Disruption of calpain reduces lipotoxicity-induced cardiac injury by preventing endoplasmic reticulum stress. , 2016, Biochimica et biophysica acta.

[91]  Z. Giricz,et al.  Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress. , 2016, American journal of physiology. Heart and circulatory physiology.

[92]  Y. Gao,et al.  Cardiac damage and dysfunction in diabetic cardiomyopathy are ameliorated by Grx1. , 2016, Genetics and molecular research : GMR.

[93]  Lawrence A Leiter,et al.  Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. , 2016, The New England journal of medicine.

[94]  Jun Ren,et al.  Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1α , 2016, Oncotarget.

[95]  P. Umbarkar,et al.  Mitochondrial Peroxiredoxin-3 protects against hyperglycemia induced myocardial damage in Diabetic cardiomyopathy. , 2016, Free radical biology & medicine.

[96]  B. Rodrigues,et al.  Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy. , 2016, Cardiovascular research.

[97]  T. Minamino,et al.  Physiological and pathological cardiac hypertrophy. , 2016, Journal of molecular and cellular cardiology.

[98]  A. Mahmoud,et al.  Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats , 2016, Drug design, development and therapy.

[99]  J. Buse,et al.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.

[100]  Gregory M. Fomovsky,et al.  Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart. , 2016, American journal of physiology. Heart and circulatory physiology.

[101]  Jinzi Wu,et al.  Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications , 2016, Diabetes, metabolic syndrome and obesity : targets and therapy.

[102]  C. Borza,et al.  Assessment of Mitochondrial Dysfunction and Monoamine Oxidase Contribution to Oxidative Stress in Human Diabetic Hearts , 2016, Oxidative medicine and cellular longevity.

[103]  C. Lombardi,et al.  Novel insight into the dangerous connection between diabetes and heart failure , 2016, Herz.

[104]  S. Baker,et al.  Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice , 2016, BioMed research international.

[105]  H. Colecraft,et al.  Inhibition of NAPDH Oxidase 2 (NOX2) Prevents Oxidative Stress and Mitochondrial Abnormalities Caused by Saturated Fat in Cardiomyocytes , 2016, PloS one.

[106]  S. Solomon,et al.  Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. , 2015, The New England journal of medicine.

[107]  Y. Xuan,et al.  Cardiac-specific overexpression of catalase prevents diabetes-induced pathological changes by inhibiting NF-κB signaling activation in the heart. , 2015, Journal of molecular and cellular cardiology.

[108]  B. Zinman,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.

[109]  T. Peng,et al.  Abstract 13631: Therapeutic Inhibition of Mitochondrial Reactive Oxygen Species With Mito-tempo Reduces Diabetic Cardiomyopathy , 2015, Circulation.

[110]  R. Sultana,et al.  Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. , 2015, The Journal of nutritional biochemistry.

[111]  S. Xiong,et al.  Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy , 2015, Diabetes.

[112]  R. Ritchie,et al.  Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling. , 2015, Free radical biology & medicine.

[113]  S. Cortassa,et al.  Impaired mitochondrial energy supply coupled to increased H2O2 emission under energy/redox stress leads to myocardial dysfunction during Type I diabetes. , 2015, Clinical science.

[114]  S. Bodhankar,et al.  Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy. , 2015, Free radical biology & medicine.

[115]  William T. Clarke,et al.  Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes , 2015, Diabetes.

[116]  Jiliang Wu,et al.  Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK , 2015, Molecular and Cellular Endocrinology.

[117]  Y. Duan,et al.  N-Acetyl Cysteine improves the diabetic cardiac function: possible role of fibrosis inhibition , 2015, BMC Cardiovascular Disorders.

[118]  A. Natali,et al.  Attenuation of Ca2+ homeostasis, oxidative stress, and mitochondrial dysfunctions in diabetic rat heart: insulin therapy or aerobic exercise? , 2015, Journal of applied physiology.

[119]  W. Paulus,et al.  Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. , 2015, European heart journal.

[120]  S. Susen,et al.  Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice. , 2015, Molecular nutrition & food research.

[121]  Junfeng Ma,et al.  Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria , 2015, Proceedings of the National Academy of Sciences.

[122]  P. Carmeliet,et al.  Metabolic adaptations in diabetic endothelial cells. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[123]  Scott Abernathy,et al.  Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy , 2015, Molecular metabolism.

[124]  J. V. Van Eyk,et al.  Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity[S] , 2015, Journal of Lipid Research.

[125]  Z. Giricz,et al.  Cardiac NO signalling in the metabolic syndrome , 2015, British journal of pharmacology.

[126]  Dongdong Sun,et al.  A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: role of AMPK-regulated autophagy. , 2015, Biochimica et biophysica acta.

[127]  Satoru Kobayashi,et al.  Autophagy and mitophagy in diabetic cardiomyopathy. , 2015, Biochimica et biophysica acta.

[128]  Pál Pacher,et al.  Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. , 2015, Biochimica et biophysica acta.

[129]  P. Couvreur,et al.  Squalenoyl Adenosine Nanoparticles provide Neuroprotection after Stroke and Spinal Cord Injury , 2014, Nature nanotechnology.

[130]  C. Dessy,et al.  AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes. , 2014, American journal of physiology. Heart and circulatory physiology.

[131]  L. Cai,et al.  Diabetic Cardiomyopathy and Its Prevention by Nrf2: Current Status , 2014, Diabetes & metabolism journal.

[132]  D. Loiselle,et al.  Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart. , 2014, American journal of physiology. Cell physiology.

[133]  Jie Liu,et al.  Effects of Advanced Glycation End Products on Calcium Handling in Cardiomyocytes , 2014, Cardiology.

[134]  R. Neviere,et al.  Myocardial Contractile Dysfunction Is Associated With Impaired Mitochondrial Function and Dynamics in Type 2 Diabetic but Not in Obese Patients , 2014, Circulation.

[135]  N. Kaludercic,et al.  Monoamine oxidases as sources of oxidants in the heart. , 2014, Journal of molecular and cellular cardiology.

[136]  J. Sowers,et al.  Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity. , 2014, Metabolism: clinical and experimental.

[137]  B. Casadei,et al.  Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease. , 2014, Journal of molecular and cellular cardiology.

[138]  P. Reaven,et al.  p38α mitogen-activated kinase mediates cardiomyocyte apoptosis induced by palmitate. , 2014, Biochemical and biophysical research communications.

[139]  L. Cai,et al.  Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage , 2014, Journal of diabetes investigation.

[140]  Liang-Jun Yan.  Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress , 2014, Journal of diabetes research.

[141]  C. G. Perry,et al.  Impairments in mitochondrial palmitoyl‐CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats , 2014, The Journal of physiology.

[142]  Yuan Zhang,et al.  Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies , 2014, Acta Diabetologica.

[143]  M. Essop,et al.  The detrimental effects of acute hyperglycemia on myocardial glucose uptake. , 2014, Life sciences.

[144]  Q. Yang,et al.  Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice , 2014, Journal of cellular and molecular medicine.

[145]  M. Wenk,et al.  The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease. , 2014, Free radical biology & medicine.

[146]  S. Chakrabarti,et al.  Metallothionein prevents cardiac pathological changes in diabetes by modulating nitration and inactivation of cardiac ATP synthase. , 2014, The Journal of nutritional biochemistry.

[147]  S. Greco,et al.  Nitric Oxide, Oxidative Stress, and p66Shc Interplay in Diabetic Endothelial Dysfunction , 2014, BioMed research international.

[148]  Zhi-xin Guo,et al.  Effect of exenatide on the cardiac expression of adiponectin receptor 1 and NADPH oxidase subunits and heart function in streptozotocin-induced diabetic rats , 2014, Diabetology & Metabolic Syndrome.

[149]  Anindita Das,et al.  Mammalian Target of Rapamycin (mTOR) Inhibition with Rapamycin Improves Cardiac Function in Type 2 Diabetic Mice , 2013, The Journal of Biological Chemistry.

[150]  Tzindilú Molina-Muñoz,et al.  Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome. , 2013, American journal of physiology. Heart and circulatory physiology.

[151]  N. Sundaresan,et al.  Defective Nrf2-dependent redox signalling contributes to microvascular dysfunction in type 2 diabetes. , 2013, Cardiovascular research.

[152]  W. Wang,et al.  Heme Oxygenase-1 Prevents Cardiac Dysfunction in Streptozotocin-Diabetic Mice by Reducing Inflammation, Oxidative Stress, Apoptosis and Enhancing Autophagy , 2013, PloS one.

[153]  W. Kuo,et al.  Diallyl trisufide (DATS) suppresses high glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFκB signaling via attenuating ROS generation. , 2013, International journal of cardiology.

[154]  Gerald W. Hart,et al.  Diabetic Hyperglycemia activates CaMKII and Arrhythmias by O linked Glycosylation , 2013, Nature.

[155]  T. Murohara,et al.  Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes. , 2013, American journal of physiology. Heart and circulatory physiology.

[156]  Santosh Kumar,et al.  Multiple Antioxidants Improve Cardiac Complications and Inhibit Cardiac Cell Death in Streptozotocin-Induced Diabetic Rats , 2013, PloS one.

[157]  R. Ritchie,et al.  Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. , 2013, Free radical biology & medicine.

[158]  N. Chattipakorn,et al.  Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin‐resistant rats , 2013, British journal of pharmacology.

[159]  D. Catalucci,et al.  Relationship Between Downregulation of miRNAs and Increase of Oxidative Stress in the Development of Diabetic Cardiac Dysfunction: Junctin as a Target Protein of miR-1 , 2013, Cell Biochemistry and Biophysics.

[160]  A. Sugawara,et al.  The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus , 2013, Molecular and Cellular Biology.

[161]  V. Demarco,et al.  Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats. , 2013, Endocrinology.

[162]  Xiaokun Li,et al.  Metallothionein prevents diabetes-induced cardiac pathological changes, likely via the inhibition of succinyl-CoA:3-ketoacid coenzyme A transferase-1 nitration at Trp(374). , 2013, American journal of physiology. Endocrinology and metabolism.

[163]  M. Powell,et al.  Reversal of mitochondrial proteomic loss in Type 1 diabetic heart with overexpression of phospholipid hydroperoxide glutathione peroxidase. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[164]  D. Feldman,et al.  Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor. , 2013, Clinical science.

[165]  L. Cai,et al.  Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation. , 2013, Journal of molecular and cellular cardiology.

[166]  E. Lewandowski,et al.  MITOCHONDRIA-TARGETED ANTIOXIDANT AMELIORATES DIET-INDUCED DIABETES AND DIASTOLIC DYSFUNCTION , 2013 .

[167]  Yan Li,et al.  Palmitate induces H9c2 cell apoptosis by increasing reactive oxygen species generation and activation of the ERK1/2 signaling pathway. , 2013, Molecular medicine reports.

[168]  C. Palmeira,et al.  The NAD ratio redox paradox: why does too much reductive power cause oxidative stress? , 2013, Toxicology mechanisms and methods.

[169]  Sang Min Park,et al.  Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials , 2013, BMJ.

[170]  Chao Liu,et al.  Curcumin Alleviates Diabetic Cardiomyopathy in Experimental Diabetic Rats , 2012, PloS one.

[171]  R. Sheervalilou,et al.  Long-term treatment with resveratrol attenuates oxidative stress pro-inflammatory mediators and apoptosis in streptozotocin-nicotinamide-induced diabetic rats. , 2012, General physiology and biophysics.

[172]  H. Raza,et al.  Alterations in Glutathione Redox Metabolism, Oxidative Stress, and Mitochondrial Function in the Left Ventricle of Elderly Zucker Diabetic Fatty Rat Heart , 2012, International journal of molecular sciences.

[173]  E. Abel,et al.  Insulin resistance: metabolic mechanisms and consequences in the heart. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[174]  An-Sheng Cheng,et al.  Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells. , 2012, Journal of agricultural and food chemistry.

[175]  G. Striker,et al.  Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1 , 2012, Proceedings of the National Academy of Sciences.

[176]  J. Tamargo,et al.  Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats. , 2012, Free radical biology & medicine.

[177]  G. Reaven.  Insulin resistance and coronary heart disease in nondiabetic individuals. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[178]  M. Irwin,et al.  Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin‐induced diabetes , 2012, Diabetes/metabolism research and reviews.

[179]  J. Yates,et al.  Modulation of Dynamin-related Protein 1 (DRP1) Function by Increased O-linked-β-N-acetylglucosamine Modification (O-GlcNAc) in Cardiac Myocytes* , 2012, The Journal of Biological Chemistry.

[180]  K. Griendling,et al.  Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System , 2012, Circulation research.

[181]  L. Cai,et al.  Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy , 2012, Experimental diabetes research.

[182]  B. Weimer,et al.  Genetic loss of insulin receptors worsens cardiac efficiency in diabetes. , 2012, Journal of molecular and cellular cardiology.

[183]  K. Walsh,et al.  The Polyphenols Resveratrol and S17834 Prevent the Structural and Functional Sequelae of Diet-Induced Metabolic Heart Disease in Mice , 2012, Circulation.

[184]  W. Kuo,et al.  NADPH oxidase‐derived superoxide Anion‐induced apoptosis is mediated via the JNK‐dependent activation of NF‐κB in cardiomyocytes exposed to high glucose , 2012, Journal of cellular physiology.

[185]  R. Ritchie,et al.  Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes , 2012, Diabetologia.

[186]  S. Bailey,et al.  Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes. , 2012, American journal of physiology. Cell physiology.

[187]  J. Das,et al.  Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis. , 2012, Toxicology and applied pharmacology.

[188]  G. Dakhale,et al.  Supplementation of Vitamin C Reduces Blood Glucose and Improves Glycosylated Hemoglobin in Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study , 2011, Advances in pharmacological sciences.

[189]  J. Woo,et al.  Mitochondria-targeted Antioxidants Protect Pancreatic β-cells against Oxidative Stress and Improve Insulin Secretion in Glucotoxicity and Glucolipotoxicity , 2011, Cellular Physiology and Biochemistry.

[190]  L. Bertrand,et al.  NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1. , 2011, Cardiovascular research.

[191]  Steven P Jones,et al.  Cardiac overexpression of 8-oxoguanine DNA glycosylase 1 protects mitochondrial DNA and reduces cardiac fibrosis following transaortic constriction. , 2011, American journal of physiology. Heart and circulatory physiology.

[192]  Y. Li,et al.  Targeted Inhibition of Calpain Reduces Myocardial Hypertrophy and Fibrosis in Mouse Models of Type 1 Diabetes , 2011, Diabetes.

[193]  P. Schrauwen,et al.  Lipotoxicity in type 2 diabetic cardiomyopathy. , 2011, Cardiovascular research.

[194]  A. Ahmadi,et al.  Effect of vitamin C supplementation on postprandial oxidative stress and lipid profile in type 2 diabetic patients. , 2011, Pakistan journal of biological sciences : PJBS.

[195]  P. Rondó,et al.  The relationship between plasma alpha-tocopherol concentration and vitamin E intake in patients with type 2 diabetes mellitus. , 2011, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[196]  Michael D. Pluth,et al.  Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis , 2011, Proceedings of the National Academy of Sciences.

[197]  K. Mahmoud,et al.  Effect of N‐acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: A randomized controlled trial , 2011, Acta anaesthesiologica Scandinavica.

[198]  Iain McDonald,et al.  Thioredoxin Reductase-2 Is Essential for Keeping Low Levels of H2O2 Emission from Isolated Heart Mitochondria* , 2011, The Journal of Biological Chemistry.

[199]  A. Kosaki,et al.  Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin‐induced diabetic mice , 2011, Clinical and experimental pharmacology & physiology.

[200]  S. Chowdhury,et al.  Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. , 2011, Diabetes research and clinical practice.

[201]  Roberta Menabò,et al.  Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. , 2011, Biochimica et biophysica acta.

[202]  Nathan D. Roe,et al.  Inhibition of NADPH oxidase alleviates experimental diabetes‐induced myocardial contractile dysfunction , 2011, Diabetes, obesity & metabolism.

[203]  A. Makino,et al.  Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytes. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[204]  M. Powell,et al.  Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: Contribution of protein import dysfunction , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[205]  S. Rohrbach,et al.  Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. , 2011, Journal of the American College of Cardiology.

[206]  Xiaokun Li,et al.  Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress–Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo , 2011, Diabetes.

[207]  D. J. Veldhuisen,et al.  Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients , 2011, European journal of heart failure.

[208]  E.R. Galimov,et al.  The Role of p66shc in Oxidative Stress and Apoptosis , 2010, Acta naturae.

[209]  Ferdinando Giacco,et al.  Oxidative stress and diabetic complications. , 2010, Circulation research.

[210]  O. Yasuda,et al.  Ezetimibe Ameliorates Cardiovascular Complications and Hepatic Steatosis in Obese and Type 2 Diabetic db/db Mice , 2010, Journal of Pharmacology and Experimental Therapeutics.

[211]  M. Murphy,et al.  Prevention of diabetic nephropathy in Ins2+/−AkitaJ mice by the mitochondria-targeted therapy MitoQ , 2010, The Biochemical journal.

[212]  R. Brandes,et al.  NADPH oxidases in cardiovascular disease. , 2010, Free radical biology & medicine.

[213]  R. Schulz,et al.  Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. , 2010, The Journal of nutritional biochemistry.

[214]  Z. Ungvari,et al.  Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. , 2010, American journal of physiology. Heart and circulatory physiology.

[215]  T. Peng,et al.  Deficiency of Rac1 Blocks NADPH Oxidase Activation, Inhibits Endoplasmic Reticulum Stress, and Reduces Myocardial Remodeling in a Mouse Model of Type 1 Diabetes , 2010, Diabetes.

[216]  Manuela Blasa,et al.  Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid. , 2010, The Journal of nutritional biochemistry.

[217]  Hailing Li,et al.  Oxidative and nitrative modifications of alpha-enolase in cardiac proteins from diabetic rats. , 2010, Free radical biology & medicine.

[218]  D. Harrison,et al.  Therapeutic targeting of mitochondrial superoxide in hypertension , 2010, Circulation research.

[219]  H. Kaneto,et al.  Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis , 2010, Mediators of inflammation.

[220]  W. Sivitz,et al.  Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. , 2010, Antioxidants & redox signaling.

[221]  M. Patti,et al.  The role of mitochondria in the pathogenesis of type 2 diabetes. , 2010, Endocrine reviews.

[222]  N. Mariappan,et al.  NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. , 2010, Cardiovascular research.

[223]  C. Winterbourn,et al.  Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. , 2010, The Biochemical journal.

[224]  P. Neufer,et al.  Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. , 2009, Journal of the American College of Cardiology.

[225]  S. Niture,et al.  Nrf2:INrf2 (Keap1) signaling in oxidative stress. , 2009, Free radical biology & medicine.

[226]  T. Peng,et al.  Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. , 2009, Cardiovascular research.

[227]  E. Abel,et al.  Rodent models of diabetic cardiomyopathy , 2009, Disease Models & Mechanisms.

[228]  Ying Li,et al.  Rac1 Is Required for Cardiomyocyte Apoptosis During Hyperglycemia , 2009, Diabetes.

[229]  B. Ganesan,et al.  Tissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice , 2009, Diabetes.

[230]  G. Hart,et al.  Regulation of Calcium/Calmodulin-dependent Kinase IV by O-GlcNAc Modification* , 2009, The Journal of Biological Chemistry.

[231]  R. Cooksey,et al.  Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding. , 2009, Cardiovascular research.

[232]  A. Valavanidis,et al.  8-hydroxy-2′ -deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis , 2009, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[233]  D. Schade,et al.  The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C. , 2009, Metabolism: clinical and experimental.

[234]  S. Boudina,et al.  Contribution of Impaired Myocardial Insulin Signaling to Mitochondrial Dysfunction and Oxidative Stress in the Heart , 2009, Circulation.

[235]  S. Leonard,et al.  Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations. , 2009, American journal of physiology. Heart and circulatory physiology.

[236]  S. Trauger,et al.  Increased Enzymatic O-GlcNAcylation of Mitochondrial Proteins Impairs Mitochondrial Function in Cardiac Myocytes Exposed to High Glucose* , 2009, Journal of Biological Chemistry.

[237]  Rajesh Kumar,et al.  Intracellular Angiotensin II Production in Diabetic Rats Is Correlated With Cardiomyocyte Apoptosis, Oxidative Stress, and Cardiac Fibrosis , 2008, Diabetes.

[238]  J. Manson,et al.  Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. , 2008, JAMA.

[239]  Sheldon E. Litwin,et al.  Type 1 Diabetic Akita Mouse Hearts Are Insulin Sensitive but Manifest Structurally Abnormal Mitochondria That Remain Coupled Despite Increased Uncoupling Protein 3 , 2008, Diabetes.

[240]  R. Ramasamy,et al.  Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts , 2008, Cardiovascular diabetology.

[241]  C. Szabó,et al.  Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy , 2008, Journal of cellular and molecular medicine.

[242]  R. Walker,et al.  The effect of rosiglitazone on oxidative stress and insulin resistance in overweight individuals. , 2008, Diabetes research and clinical practice.

[243]  M. Duchen,et al.  Mitochondria: the hub of cellular Ca2+ signaling. , 2008, Physiology.

[244]  J. Fischer,et al.  Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy , 2008, Basic Research in Cardiology.

[245]  E. Abel,et al.  Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. , 2008, Clinical science.

[246]  M. Hamblin,et al.  Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione. , 2007, Journal of cardiac failure.

[247]  Xiaoming Sheng,et al.  Mitochondrial Energetics in the Heart in Obesity-Related Diabetes , 2007, Diabetes.

[248]  R. Andriantsitohaina,et al.  Altered Contractile Response due to Increased &bgr;3-Adrenoceptor Stimulation in Diabetic Cardiomyopathy: The Role of Nitric Oxide Synthase 1–derived Nitric Oxide , 2007, Anesthesiology.

[249]  Jun Ren,et al.  Catalase alleviates cardiomyocyte dysfunction in diabetes: role of Akt, Forkhead transcriptional factor and silent information regulator 2. , 2007, Life sciences.

[250]  J. Manson,et al.  A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. , 2007, Archives of internal medicine.

[251]  S. Rhee,et al.  Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. , 2007, Kidney international. Supplement.

[252]  L. Cai.  Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications. , 2007, Current medicinal chemistry.

[253]  E. Abel,et al.  Diabetic cardiomyopathy revisited. , 2007, Circulation.

[254]  R. Ritchie,et al.  The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo. , 2007, Journal of molecular and cellular cardiology.

[255]  K. Brismar,et al.  The antioxidant role of coenzyme Q. , 2007, Mitochondrion.

[256]  R. Caprioli,et al.  Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. , 2007, Journal of molecular and cellular cardiology.

[257]  M. Hersberger,et al.  Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress , 2007, Proceedings of the National Academy of Sciences.

[258]  M. Catalano,et al.  Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. , 2006, Endocrinology.

[259]  Qianwen Wang,et al.  Causes and characteristics of diabetic cardiomyopathy. , 2006, The review of diabetic studies : RDS.

[260]  K. Sunagawa,et al.  Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart. , 2006, American journal of physiology. Heart and circulatory physiology.

[261]  Teresa Chen,et al.  Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[262]  L. Cai.  Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. , 2006, Free radical biology & medicine.

[263]  Ann Marie Schmidt,et al.  Advanced glycation end products: sparking the development of diabetic vascular injury. , 2006, Circulation.

[264]  T. Lüscher,et al.  Diabetes Promotes Cardiac Stem Cell Aging and Heart Failure, Which Are Prevented by Deletion of the p66shc Gene , 2006, Circulation research.

[265]  D. Severson,et al.  Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin. , 2006, American journal of physiology. Heart and circulatory physiology.

[266]  L. Wold,et al.  Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme. , 2006, Free radical biology & medicine.

[267]  A. Ceylan-isik,et al.  Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch , 2006, Diabetologia.

[268]  N. Metreveli,et al.  Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. , 2006, Diabetes.

[269]  L. Szweda,et al.  Decreased complex II respiration and HNE-modified SDH subunit in diabetic heart. , 2006, Free radical biology & medicine.

[270]  C. Szabó,et al.  Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol , 2006, Pharmacological Reviews.

[271]  J. T. Saari,et al.  Cardiac Metallothionein Induction Plays the Major Role in the Prevention of Diabetic Cardiomyopathy by Zinc Supplementation , 2006, Circulation.

[272]  R. Cooksey,et al.  Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. , 2005, Endocrinology.

[273]  D. Wallace.  A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.

[274]  S. Minucci,et al.  Electron Transfer between Cytochrome c and p66Shc Generates Reactive Oxygen Species that Trigger Mitochondrial Apoptosis , 2005, Cell.

[275]  E. Lonn.  Vitamin E Supplementation, Cardiovascular Events, and Cancer—Reply , 2005 .

[276]  Robin A. J. Smith,et al.  Targeting an antioxidant to mitochondria decreases cardiac ischemia‐reperfusion injury , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[277]  L. Cai,et al.  Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. , 2005, Diabetes.

[278]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[279]  J. Dyck,et al.  Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts. , 2005, American journal of physiology. Endocrinology and metabolism.

[280]  Sanjoy Ghosh,et al.  Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion. , 2005, American journal of physiology. Heart and circulatory physiology.

[281]  A. Ceriello.  Acute hyperglycaemia: a 'new' risk factor during myocardial infarction. , 2005, European heart journal.

[282]  Roberto Pastor-Barriuso,et al.  Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality , 2005, Annals of Internal Medicine.

[283]  W. Pierce,et al.  Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. , 2004, American journal of physiology. Endocrinology and metabolism.

[284]  P. Ghezzi,et al.  Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. , 2004, Journal of molecular and cellular cardiology.

[285]  Masayuki Yamamoto,et al.  Nrf2-Keap1 defines a physiologically important stress response mechanism. , 2004, Trends in molecular medicine.

[286]  Sanjoy Ghosh,et al.  Increased efflux of glutathione conjugate in acutely diabetic cardiomyocytes. , 2004, Canadian journal of physiology and pharmacology.

[287]  R. Cooksey,et al.  Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. , 2004, Diabetes.

[288]  S. Cuzzocrea,et al.  M40403 prevents myocardial injury induced by acute hyperglycaemia in perfused rat heart. , 2004, European journal of pharmacology.

[289]  Thomas H Marwick,et al.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.

[290]  L. Wold,et al.  Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinase-dependent oxidative stress mechanism. , 2004, Biochemical and biophysical research communications.

[291]  P. Pelicci,et al.  The Life Span Determinant p66Shc Localizes to Mitochondria Where It Associates with Mitochondrial Heat Shock Protein 70 and Regulates Trans-membrane Potential* , 2004, Journal of Biological Chemistry.

[292]  F. Liu,et al.  Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[293]  N. Metreveli,et al.  Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. , 2004, Diabetes.

[294]  P. Bruneval,et al.  High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[295]  L. Cai.  Metallothionein as an Adaptive Protein Prevents Diabetes and its Toxicity , 2004, Nonlinearity in biology, toxicology, medicine.

[296]  Julio E. Pérez,et al.  Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. , 2004, The American journal of cardiology.

[297]  C. Torp‐Pedersen,et al.  Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. , 2004, Journal of the American College of Cardiology.

[298]  W. Hundley,et al.  Heart failure prevalence, incidence, and mortality in the elderly with diabetes. , 2004, Diabetes care.

[299]  A. Goldfine,et al.  Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus. , 2003, American journal of physiology. Heart and circulatory physiology.

[300]  M. Hellmich,et al.  N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. , 2003, The Journal of thoracic and cardiovascular surgery.

[301]  A. Shah,et al.  Cardiac dysfunction in the Goto-Kakizaki rat , 2003, Basic Research in Cardiology.

[302]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[303]  F. Murad,et al.  Quantitative Protein Profiling in Heart Mitochondria from Diabetic Rats* , 2003, Journal of Biological Chemistry.

[304]  F. Murad,et al.  Protein Tyrosine Nitration in the Mitochondria from Diabetic Mouse Heart , 2003, Journal of Biological Chemistry.

[305]  G. Rozanski,et al.  Regulation of glutathione in cardiac myocytes. , 2003, Journal of molecular and cellular cardiology.

[306]  L. Wold,et al.  AT1 Blockade Prevents Glucose-Induced Cardiac Dysfunction in Ventricular Myocytes: Role of the AT1 Receptor and NADPH Oxidase , 2003, Hypertension.

[307]  E. Bollano,et al.  Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. , 2003, Endocrinology.

[308]  Jeroen J. Bax,et al.  Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. , 2003, Journal of the American College of Cardiology.

[309]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[310]  Kieran Clarke,et al.  Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes , 2003, Circulation.

[311]  S. Hazen,et al.  Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. , 2003, JAMA.

[312]  C. Palmeira,et al.  Diabetes and mitochondrial oxidative stress: A study using heart mitochondria from the diabetic Goto-Kakizaki rat , 2003, Molecular and Cellular Biochemistry.

[313]  Jun Ren,et al.  Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. , 2003, Diabetes.

[314]  C. Napoli,et al.  Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[315]  Alan R. Tall,et al.  Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[316]  F. Murad,et al.  Protein Nitration in Cardiovascular Diseases , 2002, Pharmacological Reviews.

[317]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[318]  E. Bollano,et al.  Overexpression of Apolipoprotein B in the Heart Impedes Cardiac Triglyceride Accumulation and Development of Cardiac Dysfunction in Diabetic Mice* , 2002, The Journal of Biological Chemistry.

[319]  N. Baquer,et al.  Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: Effect of vanadate and fenugreek (Trigonella foenum graecum) , 2002, Molecular and Cellular Biochemistry.

[320]  A. Ceriello.  Nitrotyrosine: new findings as a marker of postprandial oxidative stress. , 2002, International journal of clinical practice. Supplement.

[321]  L. Cai,et al.  Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. , 2002, Diabetes.

[322]  K. Horiike,et al.  Reduced activity of mtTFA decreases the transcription in mitochondria isolated from diabetic rat heart. , 2002, American journal of physiology. Endocrinology and metabolism.

[323]  R. Marfella,et al.  Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. , 2002, Diabetes.

[324]  J. Sastre,et al.  Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. , 2002, Diabetes.

[325]  F. Murad,et al.  Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. , 2001, American journal of physiology. Heart and circulatory physiology.

[326]  G. Eisenhofer.  The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. , 2001, Pharmacology & therapeutics.

[327]  M. Kesavulu,et al.  Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. , 2001, Diabetes research and clinical practice.

[328]  P. Anversa,et al.  IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. , 2001, Diabetes.

[329]  D. Stuehr,et al.  Oxygen Reduction by Nitric-oxide Synthases* , 2001, The Journal of Biological Chemistry.

[330]  P. Scarpace,et al.  Mechanism for obesity-induced increase in myocardial lipid peroxidation , 2001, International Journal of Obesity.

[331]  Robin A. J. Smith,et al.  Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells , 2001, The Journal of Biological Chemistry.

[332]  A. Maseri,et al.  Myocardial Cell Death in Human Diabetes , 2000, Circulation research.

[333]  S. Yusuf,et al.  Vitamin E supplementation and cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.

[334]  B. Howard,et al.  Impact of diabetes on cardiac structure and function: the strong heart study. , 2000, Circulation.

[335]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[336]  J. Sparks,et al.  Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. , 2000, Atherosclerosis.

[337]  G. Hasenfuss,et al.  Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. , 2000, Circulation.

[338]  C. Kilo,et al.  The role of cytosolic reductive stress in oxidant formation and diabetic complications. , 1999, Diabetes research and clinical practice.

[339]  J. Miller,et al.  Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. , 1999, Journal of the American Society of Nephrology : JASN.

[340]  J. Crowley,et al.  The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. , 1999, The Journal of clinical investigation.

[341]  C. Tohyama,et al.  Metallothionein in radiation exposure: its induction and protective role. , 1999, Toxicology.

[342]  J. Keaney,et al.  Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. , 1998, Circulation research.

[343]  G. Kessler,et al.  Metabolism of fatty acids and glucose. , 1998, Circulation.

[344]  H. Maegawa,et al.  Altered Activities of Transcription Factors and Their Related Gene Expression in Cardiac Tissues of Diabetic Rats , 1998, Diabetes.

[345]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. , 1998, Journal of the American College of Cardiology.

[346]  B. Mayer,et al.  Biosynthesis and action of nitric oxide in mammalian cells. , 1997, Trends in biochemical sciences.

[347]  Y. J. Kang,et al.  Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. , 1997, The Journal of clinical investigation.

[348]  T. Miura,et al.  Antioxidant activity of metallothionein compared with reduced glutathione. , 1997, Life sciences.

[349]  I. Grupp,et al.  Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. , 1996, The American journal of physiology.

[350]  B. Zinman,et al.  Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. , 1996, Clinical science.

[351]  K. Prasad,et al.  Lipid peroxidation and activity of antioxidant enzymes in diabetic rats , 1995, Molecular and Cellular Biochemistry.

[352]  A. Griesmacher,et al.  Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. , 1995, The American journal of medicine.

[353]  P. Singal,et al.  Free radicals and the heart. , 1993, Journal of pharmacological and toxicological methods.

[354]  J. Nyengaard,et al.  Hyperglycemic Pseudohypoxia and Diabetic Complications , 1993, Diabetes.

[355]  M. Cotter,et al.  Polyol pathway‐mediated changes in cardiac muscle contractile properties: studies in streptozotocin‐diabetic and galactose‐fed rats , 1992, Experimental physiology.

[356]  J. Harlow,et al.  Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH/NAD+. , 1992, Kidney international.

[357]  N. Parinandi,et al.  Diabetic heart and kidney exhibit increased resistance to lipid peroxidation. , 1990, Biochimica et biophysica acta.

[358]  D. Godin,et al.  Alterations in tissue antioxidant systems in the spontaneously diabetic (BB Wistar) rat. , 1987, Canadian journal of physiology and pharmacology.

[359]  D. Godin,et al.  Alterations in Free Radical Tissue-Defense Mechanisms in Streptozocin-Induced Diabetes in Rat: Effects of Insulin Treatment , 1987, Diabetes.

[360]  D. Godin,et al.  Starvation-Related Alterations in Free Radical Tissue Defense Mechanisms in Rats , 1987, Diabetes.

[361]  M. Kurasaki,et al.  Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of Type 2 (non-insulin-dependent) diabetic women , 1985, Klinische Wochenschrift.

[362]  Paul J Thornalley,et al.  Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. , 1985, Biochimica et biophysica acta.

[363]  W. Kannel,et al.  Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.

[364]  K. Gabbay.  The sorbitol pathway and the complications of diabetes. , 1973, The New England journal of medicine.

[365]  A. Grishman,et al.  New type of cardiomyopathy associated with diabetic glomerulosclerosis. , 1972, The American journal of cardiology.

[366]  Peixin Yang,et al.  Oxidative stress‐induced miR‐27a targets the redox gene nuclear factor erythroid 2‐related factor 2 in diabetic embryopathy , 2018, American journal of obstetrics and gynecology.

[367]  P. Saxena,et al.  Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway. , 2016, International journal of cardiology.

[368]  S. Cortassa,et al.  Cardiovascular Consequences of Obesity and Type 2 Diabetes Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose , 2015 .

[369]  G. Fonarow,et al.  Concomitant diabetes mellitus and heart failure. , 2015, Current problems in cardiology.

[370]  Xiao-Jun Ma,et al.  Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[371]  Q. Ma,et al.  Disruption of Nrf2 Synergizes with High Glucose to Cause Heightened Myocardial Oxidative Stress and Severe Cardiomyopathy in Diabetic Mice. , 2012, Journal of diabetes & metabolism.

[372]  G. Wassmer,et al.  Preoperative statin therapy for patients undergoing cardiac surgery. , 2012, The Cochrane database of systematic reviews.

[373]  E. Anderson,et al.  Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways. , 2011, American journal of physiology. Heart and circulatory physiology.

[374]  C. Folmes,et al.  Myocardial fatty acid metabolism in health and disease. , 2010, Physiological reviews.

[375]  R. Marchase,et al.  Protein O-GlcNAcylation: A critical regulator of the cellular response to stress. , 2010, Current signal transduction therapy.

[376]  Yun Zhang,et al.  ALDH2 genetic polymorphism and the risk of type II diabetes mellitus in CAD patients , 2010, Hypertension Research.

[377]  S. Cook,et al.  Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. , 2010, European heart journal.

[378]  Q. Ma,et al.  Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. , 2009, Journal of molecular and cellular cardiology.

[379]  W. Sivitz,et al.  Superoxide and respiratory coupling in mitochondria of insulin-deficient diabetic rats. , 2009, Endocrinology.

[380]  P. Evora,et al.  Blood cardioplegia with N-acetylcysteine may reduce coronary endothelial activation and myocardial oxidative stress. , 2009, The heart surgery forum.

[381]  B. Gersh.  Vitamins E and C in the Prevention of Cardiovascular Disease in Men: The Physicians’ Health Study II Randomized Controlled Trial , 2009 .

[382]  N. Metreveli,et al.  Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes , 2007, Cardiovascular Toxicology.

[383]  L. Cai,et al.  Cell death and diabetic cardiomyopathy , 2007, Cardiovascular Toxicology.

[384]  L. Cai,et al.  Oxidative stress and diabetic cardiomyopathy , 2007, Cardiovascular Toxicology.

[385]  A. Ceylan-isik,et al.  High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus. , 2006, Journal of applied physiology.

[386]  R. Cannon,et al.  High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. , 2006, American journal of physiology. Heart and circulatory physiology.

[387]  S. Summers,et al.  Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.

[388]  K. Griendling,et al.  Serial Review : The Role of Oxidative Stress in Diabetes mellitus Serial Review , 2006 .

[389]  S. Bursell,et al.  The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients. , 2005, Diabetes.

[390]  A. Shah,et al.  Cardiac dysfunction in the Goto-Kakizaki rat. A model of type II diabetes mellitus. , 2004, Basic research in cardiology.

[391]  Q. Liang,et al.  Overexpression of metallothionein reduces diabetic cardiomyopathy. , 2002, Diabetes.

[392]  T. Belke,et al.  Effects of chronic food restriction and exercise training on the recovery of cardiac function following ischemia. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[393]  V. Palace,et al.  Regional differences in non-enzymatic antioxidants in the heart under control and oxidative stress conditions. , 1999, Journal of molecular and cellular cardiology.

[394]  Dario Giugliano.  Metabolism of Fatty Acids and Glucose , 1998 .

[395]  M. Reilly,et al.  8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. , 1997, Circulation.

[396]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.

[397]  J. Doroshow,et al.  Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. , 1980, The Journal of clinical investigation.

[398]  C. Kilo,et al.  Nephrology Dialysis Transplantation Interactions between the Sorbitol Pathway, Non-enzymatic Glycation, and Diabetic Vascular Dysfunction , 2022 .

[399]  D. Chartoumpekis,et al.  Send Orders of Reprints at Reprints@benthamscience.net New Player on an Old Field; the Keap1/nrf2 Pathway as a Target for Treatment of Type 2 Diabetes and Metabolic Syndrome , 2022 .

[400]  Chun-jun Li,et al.  O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .

[401]  P. Vegi,et al.  International Journal of Biological & Medical Research Protein Carbonyl Content as a Stable Oxidative Stress Marker in Type Ii Diabetes. International Journal of Biological and Medical Research Www.biomedscidirect.com Int J Biol Med Res , 2022 .